Search
Search Constraints
You searched for: Is Part Of Cancer journal. Volume 24:Issue 4(2018)Limit your search
- 616.994005 7
- Cancer -- Periodicals 7
- Angiogenesis -- bevacizumab -- immune checkpoint inhibitors -- kidney cancer -- PD-1/PD-L1, atezolizumab -- Renal cell carcinoma 1
- Antiangiogenesis therapy -- bevacizumab -- biosimilars -- cervical cancer 1
- Atezolizumab -- avelumab -- bevacizumab -- cancer immunotherapy -- cytotoxic T-lymphocyte antigen 4 (CTLA-4) -- durvalumab -- immuno-oncology -- nivolumab -- pembrolizumab -- programmed death 1 (PD-1) -- programmed death ligand 1 (PD-L1) -- vascular endothelial growth factor (VEGF) 1
- Bevacizumab -- cancer -- colon -- rectum -- VEGF 1
- Bevacizumab -- glioblastoma -- VEGF 1
- Cancer -- humanization -- immunotherapy 1
- Exome -- neoplasm -- sequence analysis, DNA -- targeted therapy 1